Session Description: Today in the US, it is estimated that approximately 100 million adults live with daily chronic pain and that opioid analgesics have been prescribed for up to one-third of patients in primary care clinics. The United States leads the world in the consumption of opioids. This sharp rise in usage over the past decade has led to the public health crisis linked to overdose deaths. Typically, the etiology of chronic pain is poorly suited to be managed by medications as the suffering associated with pain is more of the central issue requiring remediation. Our approach will highlight the usage of Neurotechnology i.e. (dTMS, HBOT, qEEG and NFB) and integrated psychiatry. This presentation will include the use of data to adjust treatment protocols and guide strategies for success. This process results in the empowerment of the patient as case examples and video demonstrations will be included.
Learning Objectives:
After this activity participants should be able to
Describe the impact of Neurotechnology and understanding of Neuroplasticity and other innovations in diagnosis, treatment and monitoring on treatment for those suffering from neuropathic pain.
Discuss how neurotechnology has advanced and can be used in treatment, monitoring, and recovery from chronic pain.
Describe the future usefulness of neurotechnology and neuroplastic innovations aide in diagnosis, relief, and treatment of chronic pain.
